BeStock  

Zimmer Biomet Holdings ZBH

US equityMarket cap rank #937Medical Devices
$101.10 −$0.37 (-0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $100.82 -0.28%
Open$102.72
Prev close$101.47
Day range$100.82 – $103.87
Volume2.96M
Market cap$19.13B
P/E (TTM)25.5
Dividend yield0.95%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership101.2%+0.42 pts vs. prior quarter
Institutions holding1,124-3 vs. prior quarter
Insider trades (recent)36 buys / 8 sellsNet buying
Short interest4.11% of floatDays to cover 3.9 · as of 30 Oct 2026
Short-sale volume share19.2%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%22%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$34.51M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$3.1MSuper−$31.4MBig−$12.2MMid−$6.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 39.7% of shares outstanding.

Largest holders

  • Dodge & Cox12.01%
  • BlackRock8.25%
  • Vanguard Capital Management, LLC7.16%
  • Harris Associates L.P.6.48%
  • Capital Research5.82%
  • State Street Global Advisors4.69%
  • Vanguard Portfolio Management, LLC4.30%
  • Geode Capital Management, LLC2.85%

By investor type

  • Mutual Fund88.79%
  • Hedge Fund4.44%
  • Public Company3.07%
  • Government Pension Fund2.01%
  • Private Company1.02%
  • Sovereign Wealth Fund0.93%
  • Insurance Company0.33%
  • Family Office/Trust0.25%

Reported short interest has fallen from 4.61% to 4.11% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Alyeska Investment Group, L.P. Hedge Fund 2026/Q4 +1,170,000 0.6%
Freestone Grove Partners LP Hedge Fund 2026/Q4 +1,004,008 0.5%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q4 +851,228 1.3%
ExodusPoint Capital Management, LP Hedge Fund 2026/Q4 +505,267 0.4%
Jane Street Group, LLC Private Company 2026/Q4 +394,719 0.2%
Alberta Investment Management Corporation Government Pension Fund 2026/Q4 +252,106 0.3%
Amundi Asset Management Mutual Fund 2026/Q4 +213,265 0.5%
LSV Asset Management Mutual Fund 2026/Q4 +210,992 0.2%
Invesco Ltd. Mutual Fund 2026/Q4 +196,937 0.9%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q4 +192,423 0.4%
Qube Research & Technologies Ltd Mutual Fund 2026/Q4 +183,457 0.1%
Corient Private Wealth LP Mutual Fund 2026/Q4 +167,696 0.1%
Quantinno Capital Management LP Mutual Fund 2026/Q4 +165,783 0.5%
JPMorgan Chase & Co. Public Company 2026/Q4 +165,429 0.3%
PFM Health Sciences, LP Hedge Fund 2026/Q4 +155,425 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Sep 2026 Brian Hatcher President, Recon, S.E.T., CMFT, Neuro and Biosurgery Initial Statement of Beneficial +0 – 10,425
30 Sep 2026 Gary Campbell President of Americas Derivative Exercise and Sale -1,412 $88.42 2,174
30 Sep 2026 Gary Campbell President of Americas Derivative Exercise and Retained +2,174 – 2,174
30 Sep 2026 Gary Campbell President of Americas Initial Statement of Beneficial +0 – 8,515
29 Sep 2026 Robert Hagemann Independent Director Other Derivative Acquisition +306 $89.85 33,661
29 Sep 2026 Arthur Higgins Independent Director Other Derivative Acquisition +306 $89.85 38,077
29 Sep 2026 Louis Shapiro Independent Director Other Derivative Acquisition +153 $89.85 3,865
29 Sep 2026 Maria Hilado Independent Director Other Derivative Acquisition +375 $89.85 13,392
29 Sep 2026 Michael Farrell Lead Independent Director Other Derivative Acquisition +417 $89.85 20,074
29 Sep 2026 Devdatt Kurdikar Independent Director Other Derivative Acquisition +173 $89.85 3,171
29 Sep 2026 Sreelakshmi Kolli Independent Director Other Derivative Acquisition +173 $89.85 7,034
10 Sep 2026 Kevin Thornal Former Group President of Global Businesses & Americas Open Market Disposition -5,691 $92.95 –
3 Sep 2026 Chad Phipps Senior VP, Chief Legal & Corporate Affairs Officer and Secretary Open Market Disposition -3,000 $98.35 65,231
2 Aug 2026 Chintan Desai President Asia Pacific Region Other Derivative Acquisition +10,168 – 10,168
31 Jul 2026 Kevin Thornal Former Group President of Global Businesses & Americas Derivative Exercise and Sale -4,266 $92.68 5,691
31 Jul 2026 Kevin Thornal Former Group President of Global Businesses & Americas Derivative Exercise and Retained +5,691 – 5,691
15 Jul 2026 Suketu Upadhyay Former CFO and Executive VP of Finance, Operations & Supply Chain Intent to Sell (Form 144) -7,668 $92.86 –
29 Jun 2026 Robert Hagemann Independent Director Other Derivative Acquisition +317 $86.65 33,269
29 Jun 2026 Arthur Higgins Independent Director Other Derivative Acquisition +317 $86.65 37,675
29 Jun 2026 Louis Shapiro Independent Director Other Derivative Acquisition +158 $86.65 3,703

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,848,223 4.1% 3.9
15 Oct 2026 7,959,713 4.2% 3.9
30 Sep 2026 9,745,945 5.1% 4.4
15 Sep 2026 8,576,677 4.5% 4.4
31 Aug 2026 8,788,234 4.6% 6.5
14 Aug 2026 8,795,152 4.6% 2.9

Discussion

No comments yet — be the first to weigh in on ZBH.

Sign in to join the discussion.

Scroll to Top